20 articles
Completed study of 102 older adults tested whether combined interventions can preserve brain volume and improve mobility through muscle-brain axis.
Duke University study tests whether targeted brain stimulation can reverse age-related cognitive decline and improve working memory.
Italian researchers developed a biosensor to track extracellular vesicles in blood, potentially personalizing stroke rehabilitation.
A completed pilot trial tests whether 2g/day of a novel carnosine formulation can restore neuromuscular function and quality of life in MS patients.
A 210-person trial tests whether 5-month music therapy programs — and robotic assistants — can slow cognitive decline in older adults.
Clinical trial explores how targeted light treatment could restore circadian rhythms and improve brain function in mild cognitive impairment.
Eight-week mindfulness program tested for women experiencing severe menopause symptoms after preventive ovary removal surgery.
A pilot trial tests whether group and phone-based CBT can sharpen cognition and cut chronic stress in African Americans at risk for Alzheimer's.
Small Yale study tested magic mushroom compound for chronic headaches after brain injury, tracking symptoms and inflammation markers.
12-week intensive cognitive training program tested in 76 adults with early memory problems to assess brain function improvements.
Small trial tests electrical brain stimulation to improve sleep quality and cognitive function in patients with vascular dementia.
TONTT2 tests whether erythropoietin dose and timing can be optimized to best preserve vision after traumatic optic neuropathy.
60-person study tested psilocybin alone and with CBT for major depression, measuring brain activity and inflammatory markers.
A Phase 4 RCT tests whether one bevacizumab injection matches two combined doses for neovascular AMD outcomes over 12 months.
A completed Mount Sinai RCT tested whether HBOT can improve brain blood flow and cognition in diabetic elders with mild cognitive impairment.
A completed University of Kansas trial investigates whether creatine monohydrate can support brain energy metabolism in Alzheimer's patients.
Brain scans reveal how testosterone suppression in prostate cancer treatment could lead to cognitive decline in aging men.
Large 503-patient study tested whether Actovegin could improve thinking and memory problems that persist after stroke recovery.
The EPICURO trial tests MERIVA® turmeric over 6 months to see if it protects cognition in adults with metabolic syndrome.
Small study tests psychedelic compound's safety and effectiveness against severe depression that doesn't respond to standard treatments.
